Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP

Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821
Stéphane Schaak
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cécile Cayla
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasios Lymperopoulos
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christodoulos Flordellis
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Cussac
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colette Denis
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hervé Paris
1 2
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The heterologous regulation of the α2C-adrenergic receptor (α2C-AR) was investigated in the HepG2 cell line. Binding of [3H]MK912 (α2-antagonist) to membranes from cells submitted to various treatments showed that exposure to insulin, phorbol 12-myristate 13-acetate, or dexamethasone did not affect receptor density. On the other hand, treatment with forskolin resulted in a large reduction of α2C-AR number. The effect of forskolin was mimicked by 8-br-cAMP and was abolished by the protein kinase A inhibitor, H89. The action of cAMP was slow (t 1/2 = 23 h), dose-dependent, and additive to the receptor down-regulation elicited by the α2-agonist, UK14304. Furthermore, the diminution of receptor was not caused by an increased rate of its degradation but resulted from a decrease in the steady state amounts of α2C4-mRNA. As assessed by experiments in the presence of actinomycin D, the stability of α2C4-mRNA was not affected by 8-br-cAMP or forskolin. By contrast, the activity of a luciferase construct containing the entire promoter region of the α2C4 gene (1.9 kilobase pairs) was inhibited, indicating that the primary mechanism of action of the two compounds is at the transcriptional level. Deletions in the 5′-end of this construct showed that the elements responsible for cAMP responsiveness lie within a 242-base-pair fragment of the gene promoter (nucleotides −236/+6 relative to transcription start). Band-shift experiments indicated that nuclear factors bind to this region in a cAMP-dependent manner. The determination of the actual cis- andtrans-acting elements involved will be the object of future investigation, but the present study provides evidence for transcriptional regulation of human α2C-AR by cAMP.

Footnotes

    • Received March 2, 2000.
    • Accepted June 15, 2000.
  • Send reprint requests to: Dr. Hervé Paris, INSERM Unit 388, Institut Louis Bugnard, CHU Rangueil, Bat. L3, 31403 Toulouse Cedex 4, France. E-mail: paris{at}rangueil.inserm.fr

  • This work was supported by the BIOMED 2 program PL963373 (European Commission, Brussels, Belgium).

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 58 (4)
Molecular Pharmacology
Vol. 58, Issue 4
1 Oct 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP

Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
Molecular Pharmacology October 1, 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP

Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
Molecular Pharmacology October 1, 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics